1. Pasteur Institute of Lille, INSERM UMR 1011, Lille, France; School of Medicine and University of Lille, Lille, France; Cardiology Department; Regional and Universitary Hospital of Lille; Lille France
2. Universitary and Hospital Department of FIRE (Fibrosis, Inflammation, Remodeling), University of Paris-Diderot, Sorbonne Paris Cité, Paris France; FACT (French Alliance for Cardiovascular Trials); Hospital of Bichat, Public Assistance of Hospital of Paris, Paris, France; INSERM U-1148; Paris France
3. Pasteur Institute of Lille, EGID, INSERM UMR 1011, Lille, France; School of Medicine and University of Lille, Lille, France; Cardiology Department, Regional and Universitary Hospital of Lille; Lille France
4. Department of Medicine (Cardiology) and Research Center for Metabolic Disease Center, Tokai University School of Medicine; Tokai University; Kanagawa Japan
5. Harvard Clinical Research Institute, Cardiovascular Division; Brigham and Women's Hospital and Harvard Medical School; Boston Massachusetts
6. Pasteur Institute of Lille, INSERM UMR 1167, Lille, France; School of Medicine and University of Lille, Lille, France; Cardiology Department, Regional and Universitary Hospital of Lille; Lille France
7. Heart and Vascular Center, Brigham and Women's Hospital, and Harvard Medical School; Boston Massachusetts
8. Universitary and Hospital Department of FIRE (Fibrosis, Inflammation, Remodeling), University of Paris-Diderot, Sorbonne Paris Cité, Paris France; FACT (French Alliance for Cardiovascular Trials); Hospital of Bichat, Public Assistance of Hospital of Paris, Paris, France; INSERM U-1148, Paris, France; National Heart and Lung Institute, Royal Brompton Hospital, Imperial College; London United Kingdom